Status:
UNKNOWN
3D-Conformal Radiation vs Helical Tomotherapy in Prostate Cancer
Lead Sponsor:
Ottawa Hospital Research Institute
Conditions:
Prostate Cancer
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
In this study we are comparing two forms of radiotherapy. This study is being done because it is not clear at present time whether intensity modulated radiotherapy (IMRT) can reduce side effects of ra...
Detailed Description
Radical radiation therapy plays an important role in the management of prostate cancer, yielding comparable long-term outcomes to surgery. Unfortunately, long term disease free survival data using PSA...
Eligibility Criteria
Inclusion
- A pathologic diagnosis of adenocarcinoma of the prostate
- Age greater than 18 years
- ECOG performance status of 2 or less.
- Presence of any of the following high risk features:
- Clinical stage cT3-4 or
- Gleason score 8-10 or
- Pre-treatment PSA \> 20ng/ml or
- Clinical N1/N2 or pathologic N1/N2
Exclusion
- Patients with contraindication to radical radiation therapy including inflammatory bowel disease
- Prior or active malignancy except non-melanoma skin carcinoma within 5 years of the diagnosis of prostate cancer
- Prior pelvic radiotherapy for other malignancies
- Prior cytotoxic chemotherapy
- Prior orchiectomy, radical prostatectomy, cryotherapy or thermal ablation therapy for prostate cancer
Key Trial Info
Start Date :
March 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2020
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT00326638
Start Date
March 1 2005
End Date
June 30 2020
Last Update
April 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Ottawa Hospital Regional Cancer Centre
Ottawa, Ontario, Canada, K1H 8L6